SLC1A5 and pancreatic ductal adenocarcinoma: The oncosuppressor miR-137 targets alanine, serine, cysteine, and glutamate transporter (ASCT2), negatively correlated with ASCT2 in pancreatic ductal adenocarcinoma, pancreatic cancer, glioblastoma, and CRC (134).